MicroRNA-Restricted Transgene Expression in the Retina
Author Information
Author(s): Karali Marianthi, Manfredi Anna, Puppo Agostina, Marrocco Elena, Gargiulo Annagiusi, Allocca Mariacarmela, Corte Michele Della, Rossi Settimio, Giunti Massimo, Bacci Maria Laura, Simonelli Francesca, Surace Enrico Maria, Banfi Sandro, Auricchio Alberto
Primary Institution: Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
Hypothesis
Can retinal-expressed microRNAs restrict AAV-mediated transgene expression to specific retinal cell types?
Conclusion
MicroRNA-mediated regulation can effectively restrict transgene expression in the retina to specific cell types, improving gene therapy outcomes.
Supporting Evidence
- MicroRNAs miR-124 and miR-204 were shown to effectively restrict transgene expression to specific retinal cell types.
- AAV2/5 vectors demonstrated efficient transduction in both mice and pigs.
- Low doses of AAV vectors resulted in targeted expression without off-target effects.
- Electroretinogram results indicated normal retinal function post-treatment.
Takeaway
This study shows that tiny molecules called microRNAs can help control where genes are turned on in the eye, which could make treatments for eye diseases safer and better.
Methodology
AAV2/5 vectors expressing EGFP with microRNA target sequences were injected subretinally into mice and pigs to assess transgene expression.
Potential Biases
Potential bias in interpreting results due to the use of specific animal models.
Limitations
The study primarily focused on specific microRNAs and may not generalize to all retinal conditions or other microRNAs.
Participant Demographics
C57BL/6 mice and Large White pigs were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website